Mutations in the Cu/Zn superoxide dismutase (SOD1) gene are responsible for some cases of familial amyotrophic lateral sclerosis (ALS). We have shown that SOD1 mutations can also occur in apparently sporadic ALS. To establish how often this happens we have undertaken a study of the prevalence of SODI mutations in an unselected cohort of Scottish ALS patients, with both sporadic (n = 57) and familial (n = 10) disease. Single strand conformation polymorphism analysis was used to scan for new mutations, and selective restriction enzyme digestion to screen for 11 of the 20 SOD1 mutations published to date. We detected mutations in five (50%) of the familial ALS patients and also in four (7%) of the sporadic patients. One mutation, ilell3thr, seems to be particularly prevalent in the Scottish population since it was detected in a total of 6167 (9%) unrelated cases.
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal paralytic disorder characterised by degeneration of motor neurones in the brain and spinal cord. The majority of cases are of a sporadic nature, while around 5 to 10% of cases are familial with the disorder inherited as an autosomal dominant trait with age dependent penetrance.' Sporadic and familial forms are clinically indistinguishable with death usually resulting between two and five years after onset of the illness.
Linkage to chromosome 21q22.1 was observed for a subset of ALS families in the USA, showing a degree ofgenetic heterogeneity among the familial forms.2 In 1993 a collaborative effort between several groups in the USA showed that mutations in the superoxide dismutase 1 gene (SOD1) segregated with the disease in several ALS families.' This enzyme serves to scavenge the damaging superoxide free radicals generated by normal cellular processes, these being among several free radical species thought to be implicated in many neurodegenerative disorders. 4 The SOD1 gene comprises five small exons5 making it ideal for mutation screening. Since the initial report,3 a total of 20 missense mutations has been published.f'0 SODI assays performed on red blood cells from heterozygous patients showed a reduction below 50% in enzyme activity.6 Although most loss of function mutations have a recessive rather than a dominant effect, SOD 1 is a homodimeric enzyme. Thus mutations may exert a dominant negative effect," that is, the product from the mutant allele disrupts the activity of the normal product in the dimeric enzyme. Indeed, several of the mutations mapped onto the human crystallographic structure of SOD 1 have been shown to be directly involved in dimer contact. 6 The fact that we detected three germline mutations in patients whose ALS was not thought to be inherited7 has important implications for the management of the disorder. We therefore decided to carry out a survey of SOD1 mutations in a population based cohort of ALS patients. To our knowledge this has not been done before. No new mutations were discovered in this survey. One case each of the previously reported gly93arg and glulOOgly mutations in exon 4 were detected, each time in patients with a clear family history of ALS. However, it is significant that we did detect three further examples of the ilell3thr mutation, this time in familial cases. This suggests, but does not prove, that our sporadic ile 11 3thr cases are part of an extended family in which the mutation is segregating. The relatively early deaths of the parents of the probands, together with illegitimacy in the families, make this difficult to prove. However, it is noteworthy that six of the nine SOD1 mutations in this Scottish cohort have involved the same nucleotide change in exon 4. Other investigators have observed that the average age of patients with the ile 113thr mutation is 61-2 years, SD 12-9 (n=5), with mean survival of 1-6 years, SD=10 (n=4) (R H Brown Jr, personal communication). Further population based studies should give a clearer idea of the frequency and penetrance of this mutation. Similarly, mutation at gly93, one of four conserved gly residues at which mutations occur, would also have a destabilising effect. Ile 113, on the other hand, participates in intrachain hydrogen bonding between SOD 1 monomers. Thus ile 11 3thr would adversely affect the structural integrity of the active dimeric SOD1 enzyme. 
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